Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,275 public trials 1,198 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Not yet recruiting

Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)

NCT07500285

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Prof. Dr. Cemil Taşcıoğlu City Hospital Istanbul, Turkey (Türkiye)

Prof. Dr. Cemil Taşçıoğlu City Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Not yet recruiting

Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer

NCT07495098

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLC

NCT07438600

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

NCT07498595

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

NCT07493980

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib

NCT07486648

Conditions: Advanced Non-Small-Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Shanxi Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not yet recruiting

SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC

NCT07489703

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

NCT07477808

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

NCT07485920

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
Locations: Affiliated Hospital of Qingdao University Qingdao, Shandong, China

Qingdao Central Hospital Affiliated to Rehabilitation University Qingdao, Shandong, China

Qingdao Municipal Hospital Qingdao, Shandong, China

Weihai Municipal Hospital Weihai, Shandong, China

View Trial Details

Not yet recruiting

Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples

NCT07163507

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: university hospital, Tours Tours, France

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions